The Cardiometabolic Diseases Market is expected to reach US$ 121,804.49 million by 2028 from US$ 93,494.41 million in 2021; it is estimated to grow at a CAGR of 3% during the forecast period 2022-2028. Cardiovascular disease, commonly known as Riven’s syndrome, is characterized by a group of abnormalities and symptoms that include abdominal obesity, high […]
